These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 23313815

  • 1. Efficacy of phytol-derived diterpenoid immunoadjuvants over alum in shaping the murine host's immune response to Staphylococcus aureus.
    Roy Chowdhury R, Fitch RW, Ghosh SK.
    Vaccine; 2013 Feb 06; 31(8):1178-86. PubMed ID: 23313815
    [Abstract] [Full Text] [Related]

  • 2. Immune enhancement by novel vaccine adjuvants in autoimmune-prone NZB/W F1 mice: relative efficacy and safety.
    Aachoui Y, Ghosh SK.
    BMC Immunol; 2011 Oct 24; 12():61. PubMed ID: 22024358
    [Abstract] [Full Text] [Related]

  • 3. Development and evaluation of vaccine against Staphylococcus aureus recovered from naturally occurring mastitis in she-camels.
    Aqib AI, Anjum AA, Ijaz M, Hussain R, Ahmed R, Farooqi SH, Aslam HB, Hussain K, Mehmood K, Zhang H.
    Microb Pathog; 2018 Apr 24; 117():341-347. PubMed ID: 29510207
    [Abstract] [Full Text] [Related]

  • 4. Synthetic adjuvants for vaccine formulations: evaluation of new phytol derivatives in induction and persistence of specific immune response.
    Aachoui Y, Schulte ML, Fitch RW, Ghosh SK.
    Cell Immunol; 2011 Apr 24; 271(2):308-18. PubMed ID: 21855057
    [Abstract] [Full Text] [Related]

  • 5. Antibody-mediated protection against Staphylococcus aureus dermonecrosis and sepsis by a whole cell vaccine.
    Zhang F, Jun M, Ledue O, Herd M, Malley R, Lu YJ.
    Vaccine; 2017 Jul 05; 35(31):3834-3843. PubMed ID: 28601365
    [Abstract] [Full Text] [Related]

  • 6. Molecular signatures of phytol-derived immunostimulants in the context of chemokine-cytokine microenvironment and enhanced immune response.
    Aachoui Y, Chowdhury RR, Fitch RW, Ghosh SK.
    Cell Immunol; 2011 Jul 05; 271(2):227-38. PubMed ID: 21813116
    [Abstract] [Full Text] [Related]

  • 7. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
    Hu DL, Narita K, Hyodo M, Hayakawa Y, Nakane A, Karaolis DK.
    Vaccine; 2009 Jul 30; 27(35):4867-73. PubMed ID: 19406185
    [Abstract] [Full Text] [Related]

  • 8. Monophosphoryl lipid A as a co-adjuvant in methicillin-resistant Staphylococcus aureus vaccine development: improvement of immune responses in a mouse model of infection.
    Mirshekar M, Haghighat S, Mousavi Z, Abdolghaffari AH, Yazdi MH.
    Immunol Res; 2024 Jun 30; 72(3):490-502. PubMed ID: 38383811
    [Abstract] [Full Text] [Related]

  • 9. One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A.
    Mancini F, Monaci E, Lofano G, Torre A, Bacconi M, Tavarini S, Sammicheli C, Arcidiacono L, Galletti B, Laera D, Pallaoro M, Tuscano G, Fontana MR, Bensi G, Grandi G, Rossi-Paccani S, Nuti S, Rappuoli R, De Gregorio E, Bagnoli F, Soldaini E, Bertholet S.
    PLoS One; 2016 Jun 30; 11(1):e0147767. PubMed ID: 26812180
    [Abstract] [Full Text] [Related]

  • 10. CD40 triggering induces strong cytotoxic T lymphocyte responses to heat-killed Staphylococcus aureus immunization in mice: a new vaccine strategy for staphylococcal mastitis.
    Wallemacq H, Bedoret D, Pujol J, Desmet C, Drion PV, Farnir F, Mainil J, Lekeux P, Bureau F, Fiévez L.
    Vaccine; 2012 Mar 09; 30(12):2116-24. PubMed ID: 22285272
    [Abstract] [Full Text] [Related]

  • 11. Protective efficacy of Hla-MntC-SACOL0723 fusion protein adjuvanted in alum and MPL against Staphylococcus aureus sepsis infection in mice.
    Ghaedi T, Davoodian P, Hassaniazad M, Eftekhar E, Faezi S, Abparvar AA, Einakian MA, Ahmadi K.
    J Immunol Methods; 2021 Jul 09; 494():113055. PubMed ID: 33857474
    [Abstract] [Full Text] [Related]

  • 12. Immune response and functional role of antibodies raised in heifers against a Staphylococcus aureus CP5 lysate and recombinant antigens vaccine formulated with Iscom Matrix adjuvant.
    Camussone CM, Pujato N, Renna MS, Veaute CM, Morein B, Marcipar IS, Calvinho LF.
    Vet Immunol Immunopathol; 2014 Dec 15; 162(3-4):96-107. PubMed ID: 25454469
    [Abstract] [Full Text] [Related]

  • 13. Targeting the R domain of coagulase by active vaccination protects mice against lethal Staphylococcus aureus infection.
    Qian M, Zhao T, Li R, Yang Q, Yu R, Yin Y, Zai X, Li Y, Zhang J, Xu J, Chen W.
    Microbes Infect; 2019 Dec 15; 21(3-4):163-169. PubMed ID: 30447395
    [Abstract] [Full Text] [Related]

  • 14. Phytol-based novel adjuvants in vaccine formulation: 2. Assessment of efficacy in the induction of protective immune responses to lethal bacterial infections in mice.
    Lim SY, Bauermeister A, Kjonaas RA, Ghosh SK.
    J Immune Based Ther Vaccines; 2006 Oct 23; 4():5. PubMed ID: 17059608
    [Abstract] [Full Text] [Related]

  • 15. Generation of a Novel Staphylococcus aureus Ghost Vaccine and Examination of Its Immunogenicity against Virulent Challenge in Rats.
    Vinod N, Oh S, Park HJ, Koo JM, Choi CW, Kim SC.
    Infect Immun; 2015 Jul 23; 83(7):2957-65. PubMed ID: 25964469
    [Abstract] [Full Text] [Related]

  • 16. Protective efficacy of Alum adjuvanted Amidase protein vaccine against Staphylococcus aureus infection in multiple mouse models.
    Suresh MK, Vasudevan AK, Biswas L, Biswas R.
    J Appl Microbiol; 2022 Feb 23; 132(2):1422-1434. PubMed ID: 34487603
    [Abstract] [Full Text] [Related]

  • 17. Recombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine model.
    Zhang BZ, Hua YH, Yu B, Lau CC, Cai JP, Zheng SY, Yam WC, Kao RY, Sze KH, Zheng BJ, Yuen KY, Huang JD.
    Infect Immun; 2015 Jan 23; 83(1):339-45. PubMed ID: 25368117
    [Abstract] [Full Text] [Related]

  • 18. Novel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccine.
    Chen Q, Dintaman J, Lees A, Sen G, Schwartz D, Shirtliff ME, Park S, Lee JC, Mond JJ, Snapper CM.
    Infect Immun; 2013 Jul 23; 81(7):2554-61. PubMed ID: 23649092
    [Abstract] [Full Text] [Related]

  • 19. NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.
    Schmidt CS, White CJ, Ibrahim AS, Filler SG, Fu Y, Yeaman MR, Edwards JE, Hennessey JP.
    Vaccine; 2012 Dec 14; 30(52):7594-600. PubMed ID: 23099329
    [Abstract] [Full Text] [Related]

  • 20. Clinical responses in cows vaccinated with a developed prototype killed Staphylococcus aureus mastitis vaccine.
    Hambali IU, Bhutto KR, Jesse FFA, Lawan A, Odhah MN, Wahid AH, Azmi MLM, Zakaria Z, Arsalan M, Muhammad NA, Jefri MN.
    Microb Pathog; 2018 Nov 14; 124():101-105. PubMed ID: 30114463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.